| History of Surromed | February 26, 2003 |
Gordon Ringold
|
Surromed |
Entrepreneurial Thought Leader Lectures |
| Views: 2331 |
|
| Video 10 of 14 from this talk |
- 01:59What is an Entrepreneur?
- 01:15Importance of Passion
- 01:37Being an Entrepreneur in Industry vs. Education: Team vs. Individual
- 02:46Types of Company in Biotech
- 03:20History: From Bayer to Affymax
- 02:58Biotech: Collaboration vs. Competition in Developing Affymax
- 01:56Pharmaceutical Companies: Challenges in Developing New Therapeutic Products
- 01:21Funding Challenges in Today's Market
- 01:21History of Maxygen
- 16:12History of Surromed
- 02:00Biggest Pharmaceutical Products in Industry Today
- 01:15How to Operate in a Downturn Economy
- 01:41When and How are Patents Important?
- 04:03Change the Business Plan in Response to a Changing Environment
Description
Ringold talks about Surromed's goals:
1) To improve the use of existing drugs and diagnostics
2) Right medicine for the right patient in the right dose at the right time. Ringold talks in detail about the limitations of diagnostic techniques and drug use today and how Surromed tries to find a solution to some of the problems. He shares a report by McKinsey which summarizes the status of drug discovery.
1) To improve the use of existing drugs and diagnostics
2) Right medicine for the right patient in the right dose at the right time. Ringold talks in detail about the limitations of diagnostic techniques and drug use today and how Surromed tries to find a solution to some of the problems. He shares a report by McKinsey which summarizes the status of drug discovery.
Comments 
Related Videos:
